FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308209212> ?p ?o ?g. }

• W4308209212 endingPage "1865" @default.
• W4308209212 startingPage "1865" @default.
• W4308209212 abstract "We present the interim results of the efficacy, immunogenicity, and safety of the two-dose schedules of TURKOVAC versus CoronaVac. This was a randomized, observer-blinded, non-inferiority trial (NCT04942405). Volunteers were 18–55 years old and randomized at a 1:1 ratio to receive either TURKOVAC or CoronaVac at Day 0 and Day 28, both of which are 3 μg/0.5 mL of inactivated severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) adsorbed to aluminum hydroxide. The primary efficacy outcome was the prevention of polymerase chain reaction (PCR)-confirmed symptomatic coronavirus disease 2019 (COVID-19) at least 14 days after the second dose in the modified per-protocol (mPP) group. Safety analyses were performed in the modified intention-to-treat (mITT) group. Between 22 June 2021 and 7 January 2022, 1290 participants were randomized. The mITT group consisted of 915 participants, and the mPP group consisted of 732 participants. During a median follow-up of 90 (IQR 86–90) days, the relative risk reduction with TURKOVAC compared to CoronaVac was 41.03% (95% CI 12.95–60.06) for preventing PCR-confirmed symptomatic COVID-19. The incidences of adverse events (AEs) overall were 58.8% in TURKOVAC and 49.7% in CoronaVac arms (p = 0.006), with no fatalities or grade four AEs. TURKOVAC was non-inferior to CoronaVac in terms of efficacy and demonstrated a good safety and tolerability profile." @default.
• W4308209212 created "2022-11-09" @default.
• W4308209212 creator A5001494576 @default.
• W4308209212 creator A5003156701 @default.
• W4308209212 creator A5009035877 @default.
• W4308209212 creator A5036823940 @default.
• W4308209212 creator A5040376720 @default.
• W4308209212 creator A5051133209 @default.
• W4308209212 creator A5070533803 @default.
• W4308209212 creator A5073741370 @default.
• W4308209212 creator A5081274437 @default.
• W4308209212 creator A5083126518 @default.
• W4308209212 creator A5085293984 @default.
• W4308209212 creator A5090594476 @default.
• W4308209212 date "2022-11-04" @default.
• W4308209212 modified "2023-10-01" @default.
• W4308209212 title "Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial" @default.
• W4308209212 cites W3116163512 @default.
• W4308209212 cites W3128672662 @default.
• W4308209212 cites W3178010802 @default.
• W4308209212 cites W3179399516 @default.
• W4308209212 cites W3207057321 @default.
• W4308209212 cites W3210911021 @default.
• W4308209212 cites W3211051404 @default.
• W4308209212 cites W3213047652 @default.
• W4308209212 cites W3213762690 @default.
• W4308209212 cites W3216839746 @default.
• W4308209212 cites W4200020075 @default.
• W4308209212 cites W4200120118 @default.
• W4308209212 cites W4200252704 @default.
• W4308209212 cites W4200316526 @default.
• W4308209212 cites W4200505933 @default.
• W4308209212 cites W4206258489 @default.
• W4308209212 cites W4206675538 @default.
• W4308209212 cites W4206906464 @default.
• W4308209212 cites W4210454692 @default.
• W4308209212 cites W4214625586 @default.
• W4308209212 cites W4214705826 @default.
• W4308209212 cites W4220730627 @default.
• W4308209212 cites W4292498828 @default.
• W4308209212 cites W4320156368 @default.
• W4308209212 doi "https://doi.org/10.3390/vaccines10111865" @default.
• W4308209212 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36366373" @default.
• W4308209212 hasPublicationYear "2022" @default.
• W4308209212 type Work @default.
• W4308209212 citedByCount "5" @default.
• W4308209212 countsByYear W43082092122023 @default.
• W4308209212 crossrefType "journal-article" @default.
• W4308209212 hasAuthorship W4308209212A5001494576 @default.
• W4308209212 hasAuthorship W4308209212A5003156701 @default.
• W4308209212 hasAuthorship W4308209212A5009035877 @default.
• W4308209212 hasAuthorship W4308209212A5036823940 @default.
• W4308209212 hasAuthorship W4308209212A5040376720 @default.
• W4308209212 hasAuthorship W4308209212A5051133209 @default.
• W4308209212 hasAuthorship W4308209212A5070533803 @default.
• W4308209212 hasAuthorship W4308209212A5073741370 @default.
• W4308209212 hasAuthorship W4308209212A5081274437 @default.
• W4308209212 hasAuthorship W4308209212A5083126518 @default.
• W4308209212 hasAuthorship W4308209212A5085293984 @default.
• W4308209212 hasAuthorship W4308209212A5090594476 @default.
• W4308209212 hasBestOaLocation W43082092121 @default.
• W4308209212 hasConcept C126322002 @default.
• W4308209212 hasConcept C141071460 @default.
• W4308209212 hasConcept C159654299 @default.
• W4308209212 hasConcept C168563851 @default.
• W4308209212 hasConcept C197934379 @default.
• W4308209212 hasConcept C203014093 @default.
• W4308209212 hasConcept C2778375690 @default.
• W4308209212 hasConcept C2780868878 @default.
• W4308209212 hasConcept C61943457 @default.
• W4308209212 hasConcept C71924100 @default.
• W4308209212 hasConceptScore W4308209212C126322002 @default.
• W4308209212 hasConceptScore W4308209212C141071460 @default.
• W4308209212 hasConceptScore W4308209212C159654299 @default.
• W4308209212 hasConceptScore W4308209212C168563851 @default.
• W4308209212 hasConceptScore W4308209212C197934379 @default.
• W4308209212 hasConceptScore W4308209212C203014093 @default.
• W4308209212 hasConceptScore W4308209212C2778375690 @default.
• W4308209212 hasConceptScore W4308209212C2780868878 @default.
• W4308209212 hasConceptScore W4308209212C61943457 @default.
• W4308209212 hasConceptScore W4308209212C71924100 @default.
• W4308209212 hasIssue "11" @default.
• W4308209212 hasLocation W43082092121 @default.
• W4308209212 hasLocation W43082092122 @default.
• W4308209212 hasLocation W43082092123 @default.
• W4308209212 hasOpenAccess W4308209212 @default.
• W4308209212 hasPrimaryLocation W43082092121 @default.
• W4308209212 hasRelatedWork W1968036257 @default.
• W4308209212 hasRelatedWork W2003938723 @default.
• W4308209212 hasRelatedWork W2011080690 @default.
• W4308209212 hasRelatedWork W2034828959 @default.
• W4308209212 hasRelatedWork W2047967234 @default.
• W4308209212 hasRelatedWork W2087016115 @default.
• W4308209212 hasRelatedWork W2439875401 @default.
• W4308209212 hasRelatedWork W3093324422 @default.
• W4308209212 hasRelatedWork W3211545020 @default.
• W4308209212 hasRelatedWork W4237911363 @default.
• W4308209212 hasVolume "10" @default.

• next